Skip Navigation

JNCI Journal of the National Cancer Institute 2004 96(4):252-253; doi:10.1093/jnci/96.4.252
© 2004 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Garber, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garber, K.
Related Collections
Right arrowRelated Resource
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 Oxford University Press

NEWS

Aspirin for Cancer Chemoprevention: Still a Headache?

Ken Garber

The first 150 words of the full text of this article appear below.

Almost 7 million Americans, with the full blessing of their cardiologists, now take daily aspirin to prevent heart attacks, according to the Aspirin Foundation of America. But should we take aspirin to prevent cancer? Answers remain elusive, but the current consensus is: not yet, not even for colorectal cancer, where the strongest evidence exists. "We still have a long way to go to be certain about the [cancer] benefits before we subject people to the risks of low-dose aspirin," said University of Michigan internist Mark Fendrick, M.D.


Figure Removed (Available Only in the Full Text)
View larger version (115K):
[in this window]
[in a new window]
  		Almost 7 million Americans take aspirin daily to prevent heart attacks. But should we take aspirin to prevent cancer? Answers remain elusive, but the consensus is that it is too early to make any such recommendation.

 
Two articles in this issue of the Journal contribute to the debate over aspirin cancer chemoprevention, and a third article, on aspirin and pancreatic cancer, was published . . . [Full Text of this Article]

Exploring the Mechanism

Esophageal Cancer

Feeding LOX


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Resource

Some Recent Articles on Aspirin and Cancer
J Natl Cancer Inst 2004 96: 253. [Extract] [Full Text] [PDF]